Psychiatry

 
The Role of Stress Reduction in Cardiometabolic Disease Management for Patients with Obesity
July 15, 2025

Monu Khanna, MD, discusses the benefits of behavioral strategies, including yoga, breathwork, and dancing, in reducing cardiovascular disease risk in patients with obesity.

Maternal Depression Impairs Parental Emotional Responsiveness, Daily Care for Infants, Children: Global Systematic Review
July 15, 2025

Maternal depression significantly disrupts parenting behaviors, impacting child development and emotional bonding, according to an updated international literature review.

Investigational Rapid-Acting PTSD Medication Awarded FDA Breakthrough Therapy Status: Transcend Therapeutics Update
July 10, 2025

TSND-201, a rapid-acting neuroplastogen, demonstrated statistically significant symptom improvement by day 10, which was durable throughout the study until Day 64.

Phase 2b Study of Psychedelic BPL-003 Shows Rapid, Persistent, and Significant Improvement in Treatment Resistant Depression
July 02, 2025

A single dose of BPL-003 was associated with improved MADRS scores as early as day 2 that were durable through week 8; phase 3 planning is anticipated.

Late-Life Mood Disorders Show Strong Association with Tau and Amyloid Pathology, Study Reveals
June 13, 2025

Authors say their findings support the accumulating evidence that late-life mood disorders may be a prodromal manifestation of dementia vs a risk factor alone.

Postpartum Hormonal Contraceptives Up Depression Risk by 50%: Daily Dose
June 04, 2025

Your daily dose of the clinical news you may have missed.

Bringing PPD Screening to the Forefront of Maternal Health: A Q&A with Joy Baker, MD
June 03, 2025

ACOG 2025: Joy Baker, MD, discusses the urgent need to prioritize postpartum depression screening, normalize mental health in prenatal care, and strengthen continuity between OB-GYN and primary care.

Novel 5-HT2A Agonist GM-2505 Achieves 94% Remission Rate in Phase 2a MDD Trial, With Rapid and Durable Efficacy
May 27, 2025

The novel rapid-acting psychedelic agent produced antidepressant effects within 24 hours after the first infusion, with a -18.5 point change in MADRS from baseline.

Primary Care Clinicians Diagnose Nearly Half of Youth MDD, Report Reveals, Often During a Crisis
May 21, 2025

Youth depression is often diagnosed during crisis events, underscoring the need for primary care education and enhanced collaborative care resources.

Machine Learning Model Effectively Predicts Depression Risk in Adults with COPD
May 07, 2025

The model demonstrated 70.63% accuracy for predicting depression, a common comorbidity seen in COPD and one that increases risk for negative outcomes.